Core One Labs Inc

Core One Labs Inc

Core One Labs Completes Sale of Non-Core Assets

VANCOUVER, BC / ACCESSWIRE / January 15, 2021 /Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or "Core One") is pleased to announce that further to its October 30, 2020 press release, the Company has completed the sale of certain of its non-core assets and subsidiaries in California for CAD$3,00... Read More...

Leading Microbiologist, Dr. Robert E.W. Hancock Appointed as Executive Chairman of Core One Labs

VANCOUVER, BC / ACCESSWIRE / January 7, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company" or "Core One") is pleased to announce the appointment of Dr. Robert E.W. Hancock as Executive Chairman of the Company, effective January 6, 2021.Dr. Hancock is an internationally renowned academic in Mi... Read More...

Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.

VANCOUVER, BC / ACCESSWIRE / December 24, 2020 / Core One Labs Inc. (CSE:COOL), (OTC:CLABF), (Frankfurt:LD62), (WKN:A14XHT) (the "Company") is pleased to announce that, further to its press release of October 7, 2020, it has entered into a definitive share purchase agreement (the "Purchase Agreement"), dated December 23, 2020, for the acq... Read More...